| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
2e-11 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-11 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-10 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-10 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |